The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer ...
Aquestive Therapeutics (AQST) announced receipt of positive feedback from the U.S. Food and Drug Administration prior to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback